ARA 290 10mg (RUO) Tide Labs Tide Labs The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Restore Wellness RGV McAllen's Premier Functional Medicine Clinic ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes Molecular Medicine Springer Nature Link